表紙
市場調查報告書

旋切術設備的全球市場:各類型(方向性、旋轉性、軌道性、雷射)、地區 - 市場規模,佔有率,趨勢分析 2019年∼2026年

Atherectomy Devices Market Size, Share & Trends Analysis by Type (Directional Atherectomy, Rotational Atherectomy, Orbital Atherectomy, Laser Atherectomy), by Regions, and Segment Forecasts, 2019 - 2026

出版商 Grand View Research, Inc. 商品編碼 490501
出版日期 內容資訊 英文 120 Pages
商品交期: 2-3個工作天內
價格
旋切術設備的全球市場:各類型(方向性、旋轉性、軌道性、雷射)、地區 - 市場規模,佔有率,趨勢分析 2019年∼2026年 Atherectomy Devices Market Size, Share & Trends Analysis by Type (Directional Atherectomy, Rotational Atherectomy, Orbital Atherectomy, Laser Atherectomy), by Regions, and Segment Forecasts, 2019 - 2026
出版日期: 2019年09月04日內容資訊: 英文 120 Pages
簡介

全球旋切術設備市場在2019年∼2026年間,預測將以7.0%的年複合成長率發展,到2026年成長到9億5,780萬美元的規模。由於週邊動脈疾病等的適應疾病的罹患率驟漲,預測提高旋切術設備的需求。

本報告提供全球旋切術設備市場調查,市場概要,各類型、各地區的市場規模的變化與預測,市場佔有率,市場成長要素及阻礙因素分析,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 調查方法與範圍

  • 市場區隔和範圍
  • 調查方法
  • 資訊採購
  • 資料分析
  • 市場結構與檢驗
  • 模式詳細內容
  • 二級資訊來源清單
  • 簡稱清單
  • 調查目的

第2章 摘要整理

  • 市場預測
  • 市場區隔預測

第3章 市場變數、趨勢、範圍

  • 市場預測
  • 市場區隔
  • 滲透與成長預測的製圖
  • 法律規範與償付方案
  • 市場動態
  • 商務環境分析工具

第4章 全球旋切術設備市場分析:各類型

  • 市場佔有率分析:各類型(成果值、預測值)
  • 市場區隔儀表板
  • 市場規模的變化與預測:各類型
    • 方向性
    • 旋轉性
    • 機動性
    • 雷射

第5章 全球旋切術設備市場分析:各地區

  • 市場佔有率分析:各地區(成果值、預測值)
  • 市場區隔儀表板
  • 地區市場概述
  • 企業一覽
  • SWOT分析:各地區
  • 市場規模的變化與預測:各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東、非洲

第6章 競爭分析

  • 各主要市場參與者最近的開發與影響分析
  • 策略性組成架構/競爭的分類(主要創新者,市場領導,新興企業)
  • 業者情勢
  • 企業簡介
    • Boston Scientific Corporation
    • Cardiovascular Systems Inc.
    • Medtronic plc.
    • Spectranetics
    • VOLCANO CORPORATION
    • Avinger Inc.
    • KONINKLIJKE PHILIPS N.V
    • Straub Medical AG
    • ST. JUDE MEDICAL
    • Bard Peripheral Vascular
    • CARDINAL HEALTH (CORDIS)
    • TERUMO MEDICAL CORPORATION

第7章 推薦事項

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GVR-1-68038-416-1

The global atherectomy devices market size is expected to reach USD 957.8 million by 2026, based on a new report by Grand View Research, Inc. The market is projected to register a CAGR of 7.0% over the forecast period. The demand for atherectomy devices market is anticipated to boost over the forecast period due to rapidly rising incidence of target diseases such as peripheral artery disease. Favorable patient outcomes with minimally invasive procedures is also driving demand of atherectomy devices for peripheral vascular interventions.

New technologies and product approvals are expected to boost the market for orbital and laser atherectomy devices over the forecast period. For instance, in July 2018, Cardiovascular Systems, Inc. (CSI) signed an agreement with Aerolase Corp. to co-develop a new laser atherectomy device. The agreement gave CSI an opportunity to leverage Aerolase's FDA cleared proprietary laser technology. The new laser atherectomy system will be used for treating multiple forms of peripheral arterial diseases

Further Key Findings From the Study Suggest:

  • In 2018, the directional atherectomy segment held the largest market share owing to their capability of collecting the shaved plaque in a collecting space, which reduces the risk of barotrauma, dissection, and neointimal hyperplasia.
  • Laser atherectomy devices is expected to the fastest growing segment over the next 8 years. Laser technique is perceived as to have more precision in plaque removal and cause fewer complications. It is also believed to result in lesser incidence of restenosis.
  • Geographically, North America held the largest market share in 2018 and is expected to maintain its position during the forecast period. A high prevalence of Peripheral Artery Diseases (PAD) in this region is one of the key reasons for high demand of atherectomy. Almost 8.5 million people suffer from PAD in the U.S., resulting in an annual economic burden of nearly USD 160 million.
  • Asia Pacific is anticipated to observe the fastest growth over the coming years. Improving economic conditions leading to increasing prevalence of lifestyle diseases, especially cardiovascular and peripheral, is the key reason for this growth.

Some of the key industry contributors are: Boston Scientific Corporation, Cardiovascular Systems Inc., Medtronic (Covidien), Spectranetics, VOLCANO CORPORATION, Avinger Inc., Koninklijke Philips N.V., Straub Medical AG, ST. JUDE MEDICAL, BARD Peripheral Vascular, Cardinal Health (Cordis), and Terumo IS.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Type
    • 1.1.2 Regional scope
    • 1.1.3 Estimates and forecast timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased database
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary research
    • 1.3.5 Details of primary research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity flow analysis
      • 1.6.1.1 Approach 1: Commodity flow approach
    • 1.6.2 Volume price analysis
      • 1.6.2.1 Approach 2: Volume price analysis
  • 1.7 List of Secondary Sources
  • 1.8 List of Abbreviations
  • 1.9 Objectives
    • 1.9.1 Objective 1
    • 1.9.2 Objective 2

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Lineage outlook
    • 3.1.1 Parent market outlook
  • 3.2 Market Segmentation
    • 3.2.1 Analysis
  • 3.3 Market Dynamics
    • 3.3.1 Market driver analysis
      • 3.3.1.1 Increasing prevelance of target diseases
      • 3.3.1.2 Preference to minimally invasive procedures
    • 3.3.2 Market restraint analysis
      • 3.3.2.1 Lack of level 1 evidence for atherectomy
      • 3.3.2.2 Lack of technical training for the procedures
    • 3.3.3 Industry opportunities
  • 3.4 Penetration & Growth Prospect Mapping
    • 3.4.1 Penetration & growth prospect mapping analysis
  • 3.5 Business Environment Analysis Tools
    • 3.5.1 Porter's five forces analysis
    • 3.5.2 Pestel analysis
    • 3.5.3 Major deals & strategic alliances analysis
      • 3.5.3.1 Mergers & acquisitions and joint ventures
      • 3.5.3.2 Licensing & partnerships and technology collaborations

Chapter 4 Atherectomy Devices Market: Type Analysis

  • 4.1 Atherectomy Devices Type Market Share Analysis, 2018 & 2026
  • 4.2 Atherectomy Devices Type Market: Segment Dashboard
  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Type Segment
    • 4.3.1 Directional atherectomy
      • 4.3.1.1 Directional atherectomy devices market, 2015 - 2026 (USD Million)
    • 4.3.2 Rotational atherectomy
      • 4.3.2.1 Rotational atherectomy devices market, 2015 - 2026 (USD Million)
    • 4.3.3 Orbital atherectomy
      • 4.3.3.1 Orbital atherectomy devices market, 2015 - 2026 (USD Million)
    • 4.3.4 Laser atherectomy
      • 4.3.4.1 Laser atherectomy devices market, 2015 - 2026 (USD Million)

Chapter 5 Atherectomy Devices Market: Regional Analysis

  • 5.1 Atherectomy Devices Regional Market Share Analysis, 2018 & 2026
  • 5.2 Atherectomy Devices-Regional Market: Segment Dashboard
  • 5.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
  • 5.4 List of Players at Regional Level
    • 5.4.1 North America
    • 5.4.2 Europe
    • 5.4.3 Asia Pacific
  • 5.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 5.5.1 North America
    • 5.5.2 Europe
    • 5.5.3 Asia Pacific
    • 5.5.4 Latin America
    • 5.5.5 MEA
  • 5.6 Market Size, & Forecasts, and Trend Analysis, 2015 to 2026
    • 5.6.1 North America
      • 5.6.1.1 North America Atherectomy Devices market, 2015 - 2026 (USD Million)
      • 5.6.1.2 U.S.
      • 5.6.1.2.1 Regulatory & reimbursement scenario
      • 5.6.1.2.2 U.S. Atherectomy Devices market, 2015 - 2026 (USD Million)
      • 5.6.1.3 Canada
      • 5.6.1.3.1 Regulatory & reimbursement scenario
      • 5.6.1.3.2 Canada Atherectomy Devices market, 2015- 2026 (USD Million)
    • 5.6.2 Europe
      • 5.6.2.1 Europe Atherectomy Devices market, 2015 - 2026 (USD Million)
      • 5.6.2.2 UK
      • 5.6.2.2.1 Regulatory & reimbursement scenario
      • 5.6.2.2.2 UK Atherectomy Devices market, 2015- 2026 (USD Million)
      • 5.6.2.3 Germany
      • 5.6.2.3.1 Regulatory & reimbursement scenario
      • 5.6.2.3.2 Germany Atherectomy Devices market, 2015 - 2026 (USD Million)
      • 5.6.2.4 France
      • 5.6.2.4.1 Regulatory & reimbursement scenario
      • 5.6.2.4.2 France Atherectomy Devices market, 2015 - 2026 (USD Million)
      • 5.6.2.5 Italy
      • 5.6.2.5.1 Regulatory & reimbursement scenario
      • 5.6.2.5.2 Italy Atherectomy Devices market, 2015 - 2026 (USD Million)
    • 5.6.3 Asia Pacific
      • 5.6.3.1 Asia Pacific Atherectomy Devices market, 2015 - 2026 (USD Million)
      • 5.6.3.2 Japan
      • 5.6.3.2.1 Regulatory & reimbursement scenario
      • 5.6.3.2.2 Japan Atherectomy Devices market, 2015 - 2026 (USD Million)
      • 5.6.3.3 China
      • 5.6.3.3.1 Regulatory & reimbursement scenario
      • 5.6.3.3.2 China Atherectomy Devices market, 2015 - 2026 (USD Million)
    • 5.6.4 Latin America
      • 5.6.4.1 Latin America Atherectomy Devices market, 2015 - 2026 (USD Million)
      • 5.6.4.2 Brazil
      • 5.6.4.2.1 Regulatory & reimbursement scenario
      • 5.6.4.2.2 Brazil Atherectomy Devices market, 2015 - 2026 (USD Million)
    • 5.6.5 Middle East and Africa
      • 5.6.5.1 MEA Atherectomy Devices market, 2015- 2026 (USD Million)
      • 5.6.5.2 South Africa
      • 5.6.5.2.1 Regulatory & reimbursement scenario
      • 5.6.5.2.2 South Africa Atherectomy Devices market, 2015 - 2026 (USD Million)

Chapter 6 Competitive Analysis

  • 6.1 Recent developments & impact analysis, by key market participants
  • 6.2 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, Emerging players)
  • 6.3 Vendor Landscape
    • 6.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
  • 6.4 Company Profiles
    • 6.4.1 Boston Scientific Corporation
      • 6.4.1.1 Company overview
      • 6.4.1.2 Financial performance
      • 6.4.1.3 Product benchmarking
      • 6.4.1.4 Strategic initiatives
      • 6.4.1.5 SWOT analysis
    • 6.4.2 Cardiovascular Systems Inc.
      • 6.4.2.1 Company overview
      • 6.4.2.2 Financial performance
      • 6.4.2.3 Product benchmarking
      • 6.4.2.4 Strategic initiatives
      • 6.4.2.5 SWOT analysis
    • 6.4.3 Medtronic plc.
      • 6.4.3.1 Company overview
      • 6.4.3.2 Financial performance
      • 6.4.3.3 Product benchmarking
      • 6.4.3.4 Strategic initiatives
      • 6.4.3.5 SWOT analysis
    • 6.4.4 Spectranetics
      • 6.4.4.1 Company overview
      • 6.4.4.2 Financial performance
      • 6.4.4.3 Product benchmarking
      • 6.4.4.4 Strategic initiatives
      • 6.4.4.5 SWOT analysis
    • 6.4.5 VOLCANO CORPORATION
      • 6.4.5.1 Company overview
      • 6.4.5.2 Financial performance
      • 6.4.5.3 Product benchmarking
      • 6.4.5.4 Strategic initiatives
      • 6.4.5.5 SWOT analysis
    • 6.4.6 Avinger Inc.
      • 6.4.6.1 Company overview
      • 6.4.6.2 Financial performance
      • 6.4.6.3 Product benchmarking
      • 6.4.6.4 Strategic initiatives
      • 6.4.6.5 SWOT analysis
    • 6.4.7 KONINKLIJKE PHILIPS N.V
      • 6.4.7.1 Company overview
      • 6.4.7.2 Financial performance
      • 6.4.7.3 Product benchmarking
      • 6.4.7.4 Strategic initiatives
      • 6.4.7.5 SWOT analysis
    • 6.4.8 Straub Medical AG
      • 6.4.8.1 Company overview
      • 6.4.8.2 Product benchmarking
      • 6.4.8.3 Financial performance
      • 6.4.8.4 Strategic initiatives
      • 6.4.8.5 SWOT Analysis
    • 6.4.9 ST. JUDE MEDICAL
      • 6.4.9.1 Company overview
      • 6.4.9.2 Product benchmarking
      • 6.4.9.3 Financial performance
      • 6.4.9.4 Strategic initiatives
      • 6.4.9.5 SWOT analysis
    • 6.4.10 Bard Peripheral Vascular
      • 6.4.10.1 Company overview
      • 6.4.10.2 Product benchmarking
      • 6.4.10.3 Financial performance
      • 6.4.10.4 Strategic initiatives
      • 6.4.10.5.SWOT Analysis
    • 6.4.11 CARDINAL HEALTH (CORDIS)
      • 6.4.11.1 Company overview
      • 6.4.11.2 Product benchmarking
      • 6.4.11.3 Financial performance
      • 6.4.11.4 Strategic initiatives
      • 6.4.11.5.SWOT Analysis
    • 6.4.12 TERUMO MEDICAL CORPORATION
      • 6.4.12.1 Company overview
      • 6.4.12.2 Product benchmarking
      • 6.4.12.3 Financial performance
      • 6.4.12.4 Strategic initiatives
      • 6.4.12.5.SWOT Analysis

Chapter 7 Recommendations

List of Tables

  • TABLE 1 List of secondary sources
  • TABLE 2 List of abbreviation
  • TABLE 3 List of players in North America
  • TABLE 4 List of players in Europe
  • TABLE 5 List of players in Asia Pacific
  • TABLE 6 North America atherectomy devices, by country, 2015 - 2026 (USD Million)
  • TABLE 7 North America atherectomy devices market, by type, 2015 - 2026 (USD Million)
  • TABLE 8 U.S. atherectomy devices market, by type, 2015 - 2026 (USD Million)
  • TABLE 9 Canada atherectomy devices market, by type, 2015 - 2026 (USD Million)
  • TABLE 10 Europe atherectomy devices market, by country, 2015 - 2026 (USD Million)
  • TABLE 11 Europe atherectomy devices market, by type, 2015 - 2026 (USD Million)
  • TABLE 12 UK atherectomy devices market, by type, 2015 - 2026 (USD Million)
  • TABLE 13 Germany atherectomy devices market, by type, 2015 - 2026 (USD Million)
  • TABLE 14 France atherectomy devices market, by type, 2015 - 2026 (USD Million)
  • TABLE 15 Italy atherectomy devices market, by type, 2015 - 2026 (USD Million)
  • TABLE 16 Asia Pacific atherectomy devices market, by country, 2015 - 2026 (USD Million)
  • TABLE 17 Asia Pacific atherectomy devices market, by type, 2015 - 2026 (USD Million)
  • TABLE 18 Japan atherectomy devices market, by type, 2015 - 2026 (USD Million)
  • TABLE 19 China atherectomy devices market, by type, 2015 - 2026 (USD Million)
  • TABLE 20 Latin America atherectomy devices market, by country, 2015 - 2026 (USD Million)
  • TABLE 21 Latin America atherectomy devices market, by type, 2015 - 2026 (USD Million)
  • TABLE 22 Brazil atherectomy devices market, by type, 2015 - 2026 (USD Million)
  • TABLE 23 Middle East & Africa atherectomy devices market, by country, 2015 - 2026 (USD Million)
  • TABLE 24 Middle East & Africa atherectomy devices market, by type, 2015 - 2026 (USD Million)
  • TABLE 25 South Africa atherectomy devices market, by type, 2015 - 2026 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain-based sizing &forecasting
  • FIG. 6 QFD modeling for market share assessment
  • FIG. 7 Market summary
  • FIG. 8 Market trends & outlook
  • FIG. 9 Market segmentation & scope
  • FIG. 10 Market driver relevance analysis (Current & future impact)
  • FIG. 11 Prevalence of PAD (%)
  • FIG. 12 Volume of minimally invasive surgeries, 2005 - 2015 (Thousands)
  • FIG. 13 Market restraint relevance analysis (Current &future impact)
  • FIG. 14 Penetration & growth prospect mapping
  • FIG. 15 Atherectomy devices market - PESTLE analysis
  • FIG. 16 Porter's Five Forces Analysis
  • FIG. 17 Atherectomy devices: Heat map analysis
  • FIG. 18 Atherectomy devices market type outlook key takeaways
  • FIG. 19 Atherectomy devices: Type movement analysis
  • FIG. 20 Global directional atherectomy devices market, 2015 - 2026 (USD Million)
  • FIG. 21 Above knee atherosclerosis
  • FIG. 22 Below knee atherosclerosis
  • FIG. 23 Global rotational atherectomy market, 2015 - 2026 (USD Million)
  • FIG. 24 Global orbital atherectomy devices market, 2015 - 2026 (USD Million)
  • FIG. 25 Global laser atherectomy devices market, 2015 - 2026 (USD Million)
  • FIG. 26 Atherectomy devices reional market share analysis, 2018 & 2026
  • FIG. 27 Atherectomy devices regional market: Segment dashboard
  • FIG. 28 Regional market snapshot
  • FIG. 29 North America atherectomy devices market, 2015 - 2026 (USD Million)
  • FIG. 30 U.S. atherectomy devices market, 2015 - 2026 (USD Million)
  • FIG. 31 Canada atherectomy devices market, 2015 - 2026 (USD Million)
  • FIG. 32 Europe atherectomy devices market, 2015 - 2026 (USD Million)
  • FIG. 33 UK atherectomy devices market, 2015 - 2026 (USD Million)
  • FIG. 34 Germany atherectomy devices market, 2015 - 2026 (USD Million)
  • FIG. 35 France atherectomy devices market, 2015 - 2026 (USD Million)
  • FIG. 36 Italy atherectomy devices market, 2015 - 2026 (USD Million)
  • FIG. 37 Asia Pacific atherectomy devices market, 2015 - 2026 (USD Million)
  • FIG. 38 China atherectomy devices market, 2015 - 2026 (USD Million)
  • FIG. 39 Japan atherectomy devices Market, 2015 - 2026 (USD Million)
  • FIG. 40 Latin America atherectomy devices market, 2015 - 2026 (USD Million)
  • FIG. 41 Brazil atherectomy devices market, 2015 - 2026 (USD Million)
  • FIG. 42 MEA atherectomy devices market, 2015 - 2026 (USD Million)
  • FIG. 43 South Africa atherectomy devices market, 2015 - 2026 (USD Million)
  • FIG. 44 Strategy framework
  • FIG. 45 Strategy framework / Competition categorization
  • FIG. 46 Company market position analysis (service portfolio, strategic initiatives, geographic presence)